相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Isoflavone effect on gene expression profile and biomarkers of inflammation
M. Blay et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Radiation-induced HIF-1α cell survival pathway is inhibited by soy isoflavones in prostate cancer cells
Vinita Singh-Gupta et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Lycopene in the Prevention of Gastrointestinal Toxicity of Radiotherapy
Fundagul Andic et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2009)
Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy
John M. Pendleton et al.
BMC CANCER (2008)
Management of complications of prostate cancer treatment
M. Dror Michaelson et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer
Michael Pinkawa et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Radiosensitization of prostate cancer by soy isoflavones
Julian J. Raffoul et al.
CURRENT CANCER DRUG TARGETS (2007)
Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model
Julian J. Raffoul et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
被撤回的出版物: Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo (Retracted article. See vol. 78, pg. 6028, 2018)
Julian J. Raffoul et al.
CANCER RESEARCH (2007)
The dietary soy flavonoid genistein abrogates tissue factor induction in endothelial cells induced by the atherogenic oxidized phospholipid oxPAPC
Gregor Holzer et al.
THROMBOSIS RESEARCH (2007)
Guideline for the management of clinically localized prostate cancer: 2007 update
Ian Thompson et al.
JOURNAL OF UROLOGY (2007)
Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model
Yu Wang et al.
RADIATION RESEARCH (2006)
被撤回的出版物: Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer (Retracted article. See vol. 78, pg. 5475, 2018)
Yiwei Li et al.
CANCER RESEARCH (2006)
Genistein inhibits radiation-induced activation of NF-κB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest
Julian J. Raffoul et al.
BMC CANCER (2006)
The role of isoflavones in cancer chemoprevention
FH Sarkar et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein
YW Li et al.
NEOPLASIA (2004)
Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II
JM Michalski et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Acute side effects during 3-D-planned conformal radiotherapy of prostate cancer -: Differences between patient's self-reported questionnaire and the corresponding doctor's report
G Goldner et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2003)
Soy isoflavones in the treatment of prostate cancer
M Hussain et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2003)
Effect of soy isoflavone supplementation on markers of oxidative stress in men and women
Z Djuric et al.
CANCER LETTERS (2001)
Soy isoflavone supplementation in healthy men prevents NF-κB activation by TNF-α in blood lymphocytes
JN Davis et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Genistein prevents the glucose autoxidation mediated atherogenic modification of low density lipoprotein
M Exner et al.
FREE RADICAL RESEARCH (2001)
分享论文
